Prostate Cancer - Results from #320

REVIEW UroToday

Preliminary Development of a Mindfulness-Based Group Therapy to Expand Couples' Sexual Intimacy After Prostate Cancer: A Mixed Methods Approach - Beyond the Abstract April 26, 2021

A 38-Gene Model Comprised of Key TET2-Associated Genes Shows Additive Utility to High-Risk Prostate Cancer Cases in the Prognostication of Biochemical Recurrence - Beyond the Abstract April 21, 2021

Stereotactic Body Radiotherapy and High-Dose Rate Brachytherapy Boost in Combination with Intensity Modulated Radiotherapy for Localized Prostate Cancer: A Single-Institution Propensity Score Matched Analysis - Beyond the Abstract April 15, 2021

Refining Immuno-Oncology Approaches in Metastatic Prostate Cancer: Transcending Current Limitations – Beyond the Abstract March 31, 2021

PROPOSe: A Real-Life Prospective Study of Proclarix®, a Novel Blood-Based Test to Support Challenging Biopsy Decision-Making in Prostate Cancer - Beyond the Abstract March 29, 2021

Integration of Electronic Pathology Reporting with Clinical Trial Matching for Advanced Prostate Cancer - Beyond the Abstract March 25, 2021

Adjuvant vs. Salvage Radiation Therapy after Radical Prostatectomy: Role of Decipher® in the Era of Personalized Medicine - Beyond the Abstract March 12, 2021

Health-Related Quality of Life 24-Month after Prostate Cancer Diagnosis: An Update from the Pros-IT CNR Prospective Observational Study - Beyond the Abstract March 11, 2021

[18F]DCFPyL PET/CT in Detection and Localization of Recurrent Prostate Cancer Following Prostatectomy Including Low PSA 0.5 ng/mL - Beyond the Abstract March 10, 2021

The Clinical Utility of 18F-Fluciclovine PET/CT in Biochemically Recurrent Prostate Cancer: an Academic Center Experience Post FDA Approval - Beyond the Abstract March 9, 2021

Role of Multiparametric Prostate Magnetic Resonance Imaging before Confirmatory Biopsy in Assessing the Risk of Prostate Cancer Progression during Active Surveillance - Beyond the Abstract March 3, 2021

A Systematic Review and Meta-analysis of Local Salvage Therapies After Radiotherapy for Prostate Cancer (MASTER) - Beyond the Abstract March 2, 2021

A Molecular Biomarker, MRI Imaging or Clinicopathologic Features… How Best to Risk-Stratify Men with Localized Prostate Cancer - Beyond the Abstract February 26, 2021

Retzius-Sparing Robot-Assisted Robotic Prostatectomy: Past, Present, and Future - Beyond the Abstract February 25, 2021

A Novel Imaging Based Nomogram for Predicting Post-Surgical Biochemical Recurrence and Adverse Pathology of Prostate Cancer from Pre-Operative Bi-Parametric MRI - Beyond the Abstract February 24, 2021

PET/CT Imaging of Prostate Cancer in the Era of Small Molecule Prostate Specific Membrane Antigen Targeted Tracers - Beyond the Abstract February 24, 2021

The Mutational Landscape of Metastatic Castration-Sensitive Prostate Cancer: The Spectrum Theory Revisited - Beyond the Abstract February 22, 2021

Influence of Abiraterone and Enzalutamide on Body Composition in Patients with Metastatic Castration Resistant Prostate Cancer - Beyond the Abstract February 1, 2021

Salvage Surgery in Patients with Local Recurrence After Radical Prostatectomy - Beyond the Abstract January 26, 2021

Clinical Utility of 4Kscore, ExosomeDx and Magnetic Resonance Imaging for the Early Detection of High-Grade Prostate Cancer - Beyond the Abstract January 26, 2021

Page 17 of 57